Rat peroxisomal multifunctional enzyme type 1 (perMFE-1) is a monomeric protein of β-oxidation. We have defined five functional domains (A, B, C, D and E) in the perMFE-1 based on comparison of the amino acid sequence with homologous proteins from databases and structural data of the hydratase-1\ isomerases (H1\I) and (3S)-hydroxyacyl-CoA dehydrogenases (HAD). Domain A (residues 1-190) comprises the H1\I fold and catalyses both 2-enoyl-CoA hydratase-1 and ∆$-∆#-enoyl-CoA isomerase reactions. Domain B (residues 191-280) links domain A to the (3S)-dehydrogenase region, which includes both domain C (residues 281-474) and domain D (residues 480-583). Domains C and D carry features of the dinucleotidebinding and the dimerization domains of monofunctional HADs respectively. Domain E (residues 584-722) has sequence similarity to domain D of the perMFE-1, which suggests that it has
INTRODUCTION
Multifunctional enzyme type 1 (MFE-1) has been found in mammalian mitochondria (as a membrane-associated complex) [1] , in mammalian [2] and plant peroxisomes [3] , and also in bacteria [4] . MFE-1 catalyses the second (hydration) and third (dehydrogenation) reactions of the fatty acid β-oxidation cycle. The conversion of trans-2-enoyl-CoA esters to 3-oxo intermediates proceeds via (3S)-hydroxyacyl-CoA esters [2] . In addition to 2-enoyl-CoA hydratase-1 and (3S)-hydroxyacyl-CoA dehydrogenase (HAD) activities, MFE-1 can catalyse other reactions, depending on the source of the protein [1, 3, 5, 6] . Mammalian peroxisomal MFE-1 (perMFE-1) also catalyses the ∆$-∆#-isomerization of enoyl-CoA esters [7] and this activity is suggested to contribute to the metabolism of polyunsaturated fatty acids when they are oxidized via the dienoyl-CoA isomerase-dependent pathway [8] . The proposal that isomerase activity of MFE-1 can play a physiological role is further supported by the observation that heterologous expression of rat MFE-1 in eci1∆ Saccharomyces cere isiae strain allows the strain to grow on unsaturated fatty acids [9] .
The rat perMFE-1, which is one of the most abundant proteins in peroxisomes, is a monomeric protein of 722 amino acid residues. Multiple-sequence alignment with the monofunctional homologues of perMFE-1 suggests that it is a multidomain protein. The N-terminal part of perMFE-1 belongs to the low sequence-similarity hydratase-1 isomerase (H1\I) family [10] . This family includes mechanistically diverse enzymes [11] , catalysing different reactions but utilizing the same stabilization Abbreviations used : H1/I, hydratase-1/isomerase ; HAD, (3S)-hydroxyacyl-CoA dehydrogenase ; MFE-1, multifunctional enzyme type 1 ; mfeHAD, HAD part of MFE-1 ; perMFE-1, mammalian peroxisomal MFE-1 ; PTS-1, peroxisomal targeting signal type 1. 1 To whom correspondence should be addressed (e-mail Kalervo.Hiltunen!oulu.fi).
evolved via partial gene duplication. Experiments with engineered perMFE-1 variants demonstrate that the H1\I competence of domain A requires stabilizing interactions with domains D and E. The variant His-perMFE (residues 288-479)∆, in which the domain C is deleted, is stable and has hydratase-1 activity. It is proposed that the extreme C-terminal domain E in perMFE-1 serves the following three functions : (i) participation in the folding of the N-terminus into a functionally competent H1\I fold, (ii) stabilization of the dehydrogenation domains by interaction with the domain D and (iii) the targeting of the perMFE-1 to peroxisomes via its C-terminal tripeptide.
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strategy of an oxyanion intermediate of a CoA O-ester [12] . The crystalstructure has been solved for five members of this family [13] [14] [15] [16] [17] . Among them, 4-chlorobenzoyl-CoA dehalogenase [13] is a homotrimer, whereas others are hexamers assembled as dimers of trimers. The N-terminal core domain of each subunit consists of a H1\I fold and a long C-terminal helix. The H1\I fold, formed by four ββα-spirals and a βαβα motif, binds the substrate and contains the active site. The long, ' connecting ' terminal helix links the H1\I fold to the C-terminal domain called the trimerization domain, which is formed by three α-helices. The known structures of the H\I family show that the subunits in the trimeric discs tightly interact with the neighbouring subunits, stabilizing and completing the active site of the H1\I domain. The middle part of the perMFE-1 sequence (HAD part of MFE-1, mfeHAD) is related to the mitochondrial NAD + -dependent HADs [18] , the sequence identity being 34 % with both pig and human-soluble mitochondrial HADs. Previously published structures of human and pig heart homodimeric HADs [19, 20] show that they are composed of two identical subunits, each having two domains. The larger N-terminal domain contains the Rossmann fold [21] with the dinucleotide-binding βαβ-unit [22] , whereas the smaller, mostly α-helical, domain mediates subunit-subunit interactions. CoA O-ester substrates are bound in a cleft between the domains.
The HAD domains in bacteria and both perMFE-1 and mitochondrial MFE-1 in mammals are followed by an extension of approx. 140 amino acids in length (139 in rat perMFE-1). The function of these extensions remains unknown except for the three extreme C-terminal amino acid residues (Ser-Lys-Leu-OH) in the mammalian perMFE-1, which act as peroxisomal targeting signal type 1 (PTS-1) [23] .
Our aim was to elucidate the structure-function relationship of multifunctional β-oxidation proteins, and we show that perMFE-1 can be divided into five separate domains or parts. Studies of the functional organization of perMFE-1 using deletion variants show that interaction between the N-and Cterminal regions is required to fold an enzymically active H1\I domain. The C-terminal domain E has intrinsic homology with the dimerization domain of the mfeHAD. The possible roles of the C-terminal domain of the perMFE-1 are discussed and a model of the structural organization of the perMFE-1 is proposed.
EXPERIMENTAL

Cloning of constructs
The oligonucleotides used in the present study are shown in Table 1 . DNA was synthesized by PCR using 900 ng of rat perMFE-1 cDNA [24] The open reading frame of rat MFE-1 was cloned as three copies into the pAO815 yeast expression vector ( pAO815 : : perMFE1wt) via MunI restriction sites, which were introduced by PCR using Rkokoap, Rkokokp as primers ( pUC18 : : perMFE-1wt) and applying a Multi-copy Pichia expression kit (Invitrogen, Groningen, The Netherlands). For expression in Escherichia coli, the open reading frame was cloned into the pET3a expression vector (Novagen, Madison, WI, U.S.A.). The required NdeI restriction site on the 5h-end was introduced by using a QuickChange site-directed mutagenesis kit (Stratagene) using MFEf and its reverse primer ( pET3a : : perMFE-1wt) and the required BamHI site originated from the pUC18 vector, leaving the MunI site intact for subsequent cloning. To clone the deletion variants into the pET3a vector, the pET3a : : perMFE-1wt was digested using an intrinsic NcoI site at position 211 in the perMFE-1 cDNA on the 5h-side and the MunI site on the 3h-side.
C-terminal truncations of the perMFE-1
Deletion of the nucleotides (1771-2187) coding for the residues Pro&)%-Leu(## was achieved by site-directed mutagenesis using pET3a : : perMFE-1wt as a template and Bcl140del and its reverse 
Generation of internally deleted variants of perMFE-1
The deletion of the nucleotides (862-1770) coding for the dehydrogenase domain (Ser#)"-Lys&)$) of the perMFE-1 was achieved by overlap-extension PCR using Rkokoap, Rkokokp, DHGdel and its reverse primer as 5h, 3h and deletion primers respectively. The final PCR product was cloned into pUC18 A fragment coding for the dinucleotide-binding domain (Ser#)"-Lys%'() of perMFE-1 (nucleotide residues 862-1422) was deleted with overlap-extension PCR using Rkokoap, Rkokokp, NADdelfwd and its reverse primer as 5h, 3h and deletion primers respectively. By using 140del as a 3h-primer, a C-terminal truncation was generated leading to the additional deletion of the residues Pro&)%-Leu(##. For cloning into pET3a, the inserts were digested out from pUC18 : : perMFE(281-467)∆ and pUC18 : : perMFE(281-467)∆(584-719)∆SKL vectors with NcoI and MunI enzymes. The inserts were then ligated to the similarly digested pET3a : : perMFE-1wt construct, resulting in pET3a : : perMFE(281-467)∆ and pET3a : : perMFE(281-467)∆(584-719)∆SKL constructs. The deletion of the nucleotides (883-1437) coding for the amino acid residues Trp#))-Val%(#, leaving out seven extra amino acids to the N-terminal side of the deletion and removing five residues from the C-terminal side, was achieved by overlap-extension PCR using Rkokoap, M13fwd, NADlinkerfwd and its reverse primer as 5h, 3h and deletion primers respectively. The NcoI-and MunI-digested PCR product was directly cloned into the pET3a : : perMFE-1wt expression vector as described above [ pET3a : : perMFE(288-472)∆]. The deletion of the nucleotide residues 883-1458 corresponding to the amino acid residues Trp#))-Val%(* was achieved by overlap-extension PCR using Rkokoap, M13fwd and NADB8 as 5h, 3h and deletion primers respectively. The PCR product was cloned as described above, resulting in a pET3a : : perMFE(288-479)∆ construct. For cloning into the pET15b vector, the insert was digested with NdeI and BamHI restriction enzymes and ligated to the similarly digested pET15b expression vector [ pET15b : : perMFE(288-479)∆]. The deletion of the nucleotide residues (592-1458) coding for the amino acid residues Pro"*"-Val%(* was achieved by overlapextension PCR using Rkokoap, M13fwd, linkerNADB8 and its Domain organization of the peroxisomal multifunctional enzyme type 1 
Expression of the perMFE-1wt in Pichia pastoris and purification
The pAO815 : : perMFE-1wt linearized with SalI restriction enzyme was transformed to the P. pastoris SMD1168 strain with electroporation according to the manufacturer's instructions (Invitrogen). The screening of the transformants and the expression of the target gene were performed by using HIS4 transformants according to the manufacturer's instructions (Invitrogen). Tricine (25 mM ; pH 7.6), 1 mM EDTA, 0.5 mM benzamidine (BA), 0.1 mM PMSF and 0.02 % NaN $ were added to the cells (2.5 g wet wt.) in a final volume of 30 ml. After addition of (NH % ) # SO % to a final concentration of 0.75 M, the cells were disrupted with a French press (Spectronic, Rochester, NY, U.S.A.). The cell lysate was centrifuged at 12 000 g for 10 min at 4 mC and the resulting supernatant was recentrifuged at 100 000 g for 1 h at 5 mC. The supernatant was filtered through glass wool to remove lipids and applied on to a butyl-Sepharose Fast-Flow column (2.5 cmi10 cm ; Amersham Pharmacia Biotech) equilibrated with 25 mM Tricine (pH 7.6), 1 mM EDTA and 0.75 M (NH % ) # SO % . The bound proteins were eluted in 25 mM Tricine (pH 7.6) and 1 mM EDTA with a linear gradient of 0.75-0 M (NH % ) # SO % , with concomitant increase in ethylene glycol from 0 to 30 % in 75 ml. Fractions containing the hydratase-1 activity were pooled, concentrated to 15 ml on a Macrosep 10 K ultrafiltration membrane (Pall Filtron Corporation, Northborough, MA, U.S.A.) and dialysed against 1.5 litres of 50 mM potassium phosphate buffer (pH 6.8) and 1 mM EDTA. The sample was applied on to a 6 ml Resource S column (Amersham Pharmacia Biotech) equilibrated with the dialysis buffer. The protein was eluted with a linear gradient of KCl from 0 to 0.1 M in 60 ml. The activity containing fractions were pooled, concentrated with a Biomax-10K centrifugal filter (Millipore Corporation, Bedford, MA, U.S.A.) and applied on to a Superdex-200 HR 10\30 size-exclusion column (Amersham Pharmacia Biotech) equilibrated with 25 mM Tricine (pH 8.0), 1 mM EDTA, 0.2 M NaCl, 0.02 % NaN $ and 15 % glycerol. The perMFE-1wt-containing fractions were pooled and concentrated on centrifugal filters.
Expression of perMFE-1 variants in E. coli and purification of HisperMFE(288-479)∆
The E. coli pET expression constructs were transformed to the BL21pLysS cells and the expression was performed according to the manufacturer's instructions (Novagen). The expressions were conducted for 3 h at 30 mC. The cells were harvested, washed with PBS buffer and stored at k70 mC until use. The cell pellets were suspended in cold lysis buffer [ 
Enzyme assay
The 2-enoyl-CoA hydratase-1 activity was measured by following the rate of generation of (3S)-hydroxyacyl-CoA ester, which was oxidized in the presence of HAD and NAD + as described previously [26] , by using trans-2-decenoyl-CoA or trans-2-hexenoylCoA as substrate. To measure the combined activity of the perMFE-1 (combined action of 2-enoyl-CoA hydratase-1 and HAD), the externally added HAD was omitted. ∆$-∆#-enoylCoA isomerase activity was measured as described previously [7] , except that the monitoring of NADH was replaced by monitoring the Mg# + -3-oxoacyl-CoA complex at 303 nm. The kinetic parameters of the 2-enoyl-CoA hydratase-1 and isomerase activities of perMFE-1wt and His-perMFE (288-479)∆ were determined with trans-2-decenoyl-CoA and trans-2-hexenoyl-CoA, where the substrate concentrations varied from 10 to 290 µM and from 10 to 180 µM respectively, whereas the kinetic parameters for the ∆$-∆#-enoyl-CoA isomerase activity of perMFE-1wt and His-perMFE(288-479)∆ were determined using 10-250 µM of trans-3-hexenoyl-CoA concentrations. The measurements were made in 50 mM Tris\HCl (pH 8.0), 50 mM KCl containing 1 mM NAD + , 1 mM sodium pyruvate, 12.5 mM MgCl # and, as auxiliary enzymes, 10 µg HAD and 20 µg -lactate dehydrogenase at 22 mC. The data were analysed with GraFit software (Sigma-Aldrich).
CD spectroscopy
A JASCO J-715 spectropolarimeter (JASCO Corporation, Hachioji City, Tokyo, Japan) was used for CD spectroscopy measurements at 20 mC. The far-UV spectra of the proteins were measured from 195 to 260 nm in 25 mM Tricine (pH 8.0), 150 mM NaCl, 15 % glycerol, with the following instrument settings : response, 1 s ; sensitivity, 20 mdeg ; speed, 50 nm\min ; path length, 1 mm ; and average of 16 scans. The melting curves were generated by monitoring the protein solution at 222 nm over a temperature gradient of 20-80 mC in a CD spectrometer with the following instrument settings : temperature increase, 50 mC\h ; response, 16 s ; sensitivity, 20 mdeg ; and path length, 1 mm.
Other methods
Protein concentrations were determined by the Bradford method (Bradford reagent ; Bio-Rad Laboratories). The concentrations of the purified proteins were estimated from the molar absorption coefficient at 280 nm [27, 28] . Proteins were separated on SDS\ PAGE (12 % gel) and blotted on to a nitrocellulose membrane (Schleicher & Schuell, Dassel, Germany) [29] . For immunodetection with an ECL2 kit (Amersham Pharmacia Biotech), antibody raised against rat perMFE-1 [7] was used as the primary antibody and anti-rabbit IgG conjugated with horseradish peroxidase was used as the secondary antibody (Bio-Rad Laboratories). The acyl-CoA esters were synthesized as described previously [26] .
RESULTS AND DISCUSSION
H1\I proteins of known structure are either homotrimers or homohexamers in which the subunits are assembled into either trimeric discs [13] or doublets of trimers [14] [15] [16] [17] . However, perMFE-1 is a monomeric enzyme and is thus unique in the H\I family. The present study examines the domain organization of perMFE-1 with a special emphasis on the domain organization and interactions required for hydratase-1 and isomerase activities.
Figure 3 Schematic representation of the wild-type and engineered variants of the rat perMFE-1
The number and a description of each construct are given on the left-hand side. The number in parentheses indicates the deleted amino acid residue. This scheme follows the domains defined in Figure 1 . The numbering indicates the last residue of the domain or the last residue included in the construct. The italic numbers on the C-terminal flanking regions indicate the first amino acid residue included in the construct. The construct ending with domain E also contains the PTS-1 (Ser-Lys-Leu-OH). If the Ser-Lys-Leu is included in the C-terminus in other constructs, it is indicated by ' SKL '. The N-terminal extension of six histidine residues is indicated by the letter ' H '. The ' j ' or 'k ' signs on the right-hand side denote the observed hydratase-1 activity of the constructs. Figure 1 shows the sequence alignment of perMFE-1 with the homologous proteins having known structures. Based on the domain organization of the H1\Is and HADs as well as the sequence similarity, perMFE-1 has been divided into five parts : A, B, C, D and E (Table 2 ). In Figure 1(a) , the N-terminal part of perMFE-1 is aligned with 2-enoyl-CoA hydratase [14] , ∆$ ,& -∆# ,% -dienoyl-CoA isomerase [15] , 4-chlorobenzoyl-CoA dehalogenase [13] , methylmalonyl-CoA decarboxylase [16] and ∆$-∆#-enoyl-CoA isomerase [17] , and in Figure 1(b) , the Cterminal half of perMFE-1 is aligned with human HAD [19] and pig HAD [20] . Domain A (residues 1-190) has sequence similarity with the H1\I fold and the connecting helix in other H1\I proteins. The alignment also shows that H1\I similarity stops after the connecting helix, and other members of the H1\I family have an additional 100 residues that fold into a trimerization domain. In perMFE-1, the corresponding position is occupied by a stretch of 89 amino acid residues (residues 191-280, domain B) separating domain A from the region similar to HADs (residues 281-583 of the perMFE-1 ; mfeHAD). Although the fold and the function of the domain B of the perMFE-1 remain unknown, the secondary structure prediction of perMFE-1 (PHD secondary structure prediction [30, 31] ) suggests that, like the trimerization domain of the multimeric H1\I, domain B is mainly α-helical.
The mfeHAD comprises a sequence related to dinucleotide binding and dimerization domains of the HADs (Figure 2b) , suggesting that the mfeHAD also folds into two domains, which are subsequently marked as C (residues 281-474) and D (residues 480-583) separated by the residues 474-479. Domain C includes a conserved Gly-X-Gly-X-X-Gly motif, known to be located in a turn between a β-strand and an α-helix of the dinucleotidebinding βαβ architecture [22] . In the soluble dimeric HADs, the dimerization domains of the subunits create a contact site between the two monomers. As suggested by sequence identity (34 %) and comparison of the predicted secondary structure elements with the known elements of the HADs, domain D can adopt a fold similar to the dimerization domain of the HAD. However, in monomeric perMFE-1, a stabilizing counterpart (the other subunit in HAD) is missing ; consequently, this structural feature has to be supplemented by another region of the perMFE-1 polypeptide. The domain D is followed by an extension of residues 584-722 with a C-terminal Ser-Lys-Leu-OH triplet and a canonical PTS-1 [32] . When this extension, marked here as domain E, was searched against PDB, the dimerization domain of HADs appeared with 32.5 % similarity. The subsequent sequence alignment of domain E with perMFE-1 ( Figure 1c ) also revealed 18 % similarity to domain D (residues 479-526), which suggests that domain E could have evolved by gene duplication from domain D and, consequently, functions as a complementary part similar to the dimerization domain of HAD. Experimental evidence also suggests a tight interaction between domains D and E. For example, it has been shown that the perMFE-1 truncated for the N-terminal 259 residues is a fully active dehydrogenase [33] , whereas variants having a deletion of ten C-terminal residues or domain E are completely inactive.
In the H1\I family, the trimerization domain is an essential component of the active site in the trimeric disc. As this domain is absent from perMFE-1, the question arises how domain A is stabilized. To investigate this aspect further, we engineered modified variants of perMFE-1 and then tested for hydratase-1 activity, an indicator of functional competence. Initially, seven modified variants were designed by deleting domains, as tentatively defined by sequence alignments (Figure 1 ) and structural data (Figures 2a and 2b) . The cDNAs encoding these variants ( Figure 3 , variants 2-6) were cloned into pET3a and the vectors were transformed into E. coli cells. When immunoblot analysis was performed using antibody raised against the rat perMFE-1 [7] , protein bands of the predicted sizes of the deletion variants were visualized in the homogenates from cells expressing the constructs, but not in the homogenates from cells transformed with the pET3a vector alone (Figure 4) . During initial screening, the bacterial cell lysate showing increased hydratase-1 activity compared with a negative control (0.177p0.040 µmol : min −" : mg −" versus 0.010p0.003 µmol : min −" : mg −" ; Table  3 ) was from cells expressing pET3a : : perMFE(281-467)∆, a (Table 3) . Similarly, truncation of the extreme C-terminal domain E [perMFE(584-722)∆] resulted in an inactivation of the hydratase-1 activity.
To characterize further the properties of the perMFE(281-467)∆ variant, the soluble extract from E. coli cells transformed with pET3a : : perMFE(281-467)∆ was applied on to a DEAE column at pH 8.8. The hydratase-1 activity was found in the flow-through. However, the activity was lost despite the addition of glycerol or salt, indicating instability of the expressed polypeptide, and this hampered further purification attempts. Therefore, additional modifications to perMFE(281-467)∆ were studied. Among the variants tested, the His-perMFE(288-479)∆p (containing Ser#)"-Thr-Pro-Ser-Gly-Ala-Ser#)) at the N-terminal deletion site, but not Ile%')-Gly-Val-Val-Ser-Gly-Asn-Cys-TyrGly-Phe-Val%(* at the C-terminal deletion site) was active and maintained the hydratase-1 activity with increased stability. To facilitate purification, a His tag with six histidine residues was added to the N-terminus ; using metal-binding affinity, hydrophobic interaction and size-exclusion chromatography, HisperMFE(288-479)∆ was purified. SDS\PAGE resulted in a single protein band of 60 kDa, and size-exclusion chromatography indicated that His-perMFE(288-479)∆ is a monomeric protein.
Expression of the wild-type perMFE-1 (perMFE-1wt) from pET3a in E. coli yielded an enzymically active protein, but the expression level was low. Subsequently, perMFE-1wt, overexpressed in yeast P. pastoris as described in the Experimental section, was purified and used for the characterization.
The kinetic characterization of the hydratase-1 activity of HisperMFE(288-479)∆ and perMFE-1wt showed that His-perMFE (288-479)∆ had higher k cat values than perMFE-1wt with both the substrates trans-2-decenoyl-CoA and trans-2-hexenoyl-CoA, the values being 130.1p4.8 s −" versus 80.1p4.8 s −" and 209.0p 2.5 s −" versus 102.1p4.1 s −" respectively. However, when isomerase activity was measured with trans-3-hexenoyl-CoA as a substrate, the k cat values were lower for His-perMFE(288-479)∆ (0.085p0.004 s −" ) than for perMFE-1wt (0.41p0.03 s −" ). Interestingly, the K m value for both substrates trans-3-hexenoyl-CoA and trans-2-hexenoyl-CoA was higher in His-perMFE(288-479)∆ than in perMFE-1wt (46.9p7.2 µM versus 23.6p6.4 µM and 38.7p1.4 µM versus 9.1p1.7 µM respectively), whereas with trans-2-decenoyl-CoA as substrate, no significant change was observed (16.6p2.5 µM versus 21.3p5.2 µM).
Because the deletion variant from perMFE-1 caused dissimilar changes in the kinetic parameters of hydratase-1 and isomerase activities, the results imply that upon deletion of domain C, the environment in the catalytic site changes, favouring the hydratase-1 activity over the ∆$-∆#-isomerase activity. There are two conserved active-site residues assigned for the hydratase-1 activity in perMFE-1, namely Glu"!$ and Glu"#$ (corresponding to Glu"%% and Glu"'% in 1DUB). The postulated active-site residue for the isomerase activity is the Glu"#$ in perMFE-1. In line with this proposal, site-directed mutagenesis experiments showed that the hydratase activities of the Glu"!$-Ala and Glu"#$-Ala variants are reduced by 3200 and 1900 times and their isomerase activities by 77 and 260 times respectively.
The secondary structure elements of perMFE-1wt and HisperMFE(288-479)∆ were analysed with CD spectroscopy in the far-UV region (195-250 nm) (Figure 5a ). The spectrum of HisperMFE(288-479)∆ showed that it is a properly folded protein.
The close similarity between the spectra of His-perMFE(288-479)∆ and perMFE-1wt indicates that the deletion of the dinucleotide-binding domain (domain C) did not cause a major change in the composition of secondary-structure elements [Jfit analysis : His-perMFE(288-479)∆ 58 % α-helix and perMFE1wt 69 % versus calculated from the predicted domain structure and secondary structure elements (Figure 1 ) within domains 69 and 63 % respectively]. The melting points, 53.3 and 44.3 mC, were derived from the second derivatives of the melting curves for perMFE-1wt and His-perMFE(288-479)∆ respectively (Figure 5b) . The difference of 9.0 mC in the melting points indicates that the His-perMFE(288-479)∆ is not as stable as perMFE-1wt.
Our studies with perMFE-1 variants suggest two modes of assembly for the five domains ( Figure 6 ). From the structural homology of domain A with enzymes of the H1\I family, it appears that the active site of domain A must be completed by interaction with another domain. This could be either domain B or the C-terminal domains D and\or E, or both. Sequence comparison suggests that domains D and E have a similar fold. Domain D is the dimerization domain of HAD, suggesting that domains D and E also interact in perMFE-1 and, therefore, form a compact structure stabilizing the whole protein. Our studies indicate that the D\E domain is required for full hydratase activity as well as for dehydrogenase activity [33] . In model (1) (Figure 6 ), domain A tightly interacts with the D\E domain, whereas in model (2), domain A tightly interacts with the domain B. Both models agree with our results. In model (2), a function can be assigned to all the domains, including domain B. Model (2) also agrees with the notion that the D\E domain is important for both the H1\I fold of domain A and the catalytic activity of domain C. Further characterization of MFE-1, aimed at crystallizing the full-length and fragments of MFE-1, are in progress. The crystal structure of the C\D\E construct [33] will give further insight into the domain organization of MFE-1. 
CONCLUSIONS
